People

Our Team

AI Therapeutics has progressed its pipeline of novel, computationally-derived and patient-directed therapies using a highly accomplished and experienced team with expertise to execute on all stages of our pipeline from inception through clinical trials. 

"AI Therapeutics is at the forefront of transforming how we match drugs to patients for the best response. Our deep learning AI technology gets smarter each time patient data is analyzed, which helps us accurately select patients to treat." - Dr. Tian Xu

Button TextButton TextButton Text
Leadership
Henri Lichenstein, Ph.D.
Tian Xu, Ph.D.
Peter Young, Ph.D.
Paul Beckett, Ph.D.
Keith Fandrick, Ph.D.
Joan Edwards
Candace Fuchs
Board of Directors
Jonathan Rothberg, Ph.D.
Gregg Fergus
George Rehm
Scientific Advisory Board
Joel Bader, Ph.D.
Brendan Manning, Ph.D
Lawrence Melvin, Ph.D
Joel Dudley, Ph.D.
Smita Krishnaswamy, Ph.D.
Murat Gunel, M.D.